Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xiaohong Pu"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
To gain insight into the clinicopathologic profile of colorectal carcinomas harboring oncogenic NTRK fusions based on eastern populations as well as make the best testing algorithm for the screen, we use pan-Trk immunohistochemistry (IHC), fluorescen
Externí odkaz:
https://doaj.org/article/8fbaaa8258a0495fa4f0febf0afb4041
Publikováno v:
Human Pathology. 115:37-46
Summary In addition to hepatoid adenocarcinoma (HAC), gastric adenocarcinoma with enteroblastic differentiation (GAED) and common adenocarcinoma (COM) could also show hepatoid differentiation, which presents a poor prognosis. To elucidate the histoge
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
To gain insight into the clinicopathologic profile of colorectal carcinomas harboring oncogenic NTRK fusions based on eastern populations as well as make the best testing algorithm for the screen, we use pan-Trk immunohistochemistry (IHC), fluorescen
Publikováno v:
Pathology, research and practice. 216(12)
Anaplastic lymphoma kinase (ALK)-rearranged renal cell carcinoma (RCC) is a rare subtype of RCC with gene fusion involving ALK at 2p23. It was first included in the renal tumor classification system by WorldHealth organization (WHO) as a distinct eme
Publikováno v:
Pathology, research and practice. 216(4)
As an increasing number of gene alterations have been discovered in intrahepatic cholangiocarcinoma (ICC), molecular targets are promising for the diagnosis and treatment of distinct subpopulations carrying unique molecular signatures. C-MET amplific
Autor:
Xi-Wei Ding, Xiaohong Pu, Liang Mao, Jun Yang, Yudong Qiu, Qing Ye, Hongyan Wu, Jiong Shi, Qin Huang, Xiangshan Fan, Jun Chen
Publikováno v:
Human Pathology. 76:100-109
Intrahepatic cholangiocarcinoma (ICC) is a subtype of primary liver cancer rarely curable by surgery that is increasing rapidly in incidence. Chromosomal translocations and amplifications of the fibroblast growth factor receptor 2 (FGFR2) locus are p
Publikováno v:
Pathology - Research and Practice. 211(6):421-425
It has been proven that chromosome 17 centromere (CEP17) amplification causes misleading human epidermal growth factor receptor 2 (HER2) gene fluorescence in situ hybridization (FISH) results, precluding anti-HER2-based therapy in some patients with